Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Bloomberg

30-Year Real Yields Starting to Look Interesting, RBC Says

Rufaro Chiriseri, head of fixed income for UK and Europe at RBC Wealth Management, discusses the outlook for Treasuries as 30-year yields climbed to levels not seen since the global financial crisis. "We're actually happy to be sort of on the shorter end," Chiriseri tells Bloomberg Television. "But at the same time, it starts to look a lot more interesting with 30-year real yields at levels that we haven't seen since the GFC."

Leia mais: 30-Year Real Yields Starting to Look Interesting, RBC Says
Grafa
Technology

Perion Network revenue nudges higher as Outmax AI adoption surges 316%

Perion Network (NASDAQ:PERI), a digital advertising technology provider specializing in AI-native execution infrastructure, disclosed its financial results for the first quarter ended March 31, 2026, highlighting a heavy structural transition toward automated marketing tools.

Leia mais: Perion Network revenue nudges higher as Outmax AI adoption surges 316%
Bloomberg

Samsung Workers to Go Ahead With Strike

Talks between Samsung Electronics and its largest labor union broke down, raising the prospect of a workers' strike. A general work stoppage will go ahead on Thursday, labor leader Choi Seung-ho told reporters. The collapse in negotiations puts the global technology supply chain at risk because Samsung is the world's biggest supplier of the chips that go into devices from data center servers to smartphones and electric vehicles. Bloomberg's Yoolim Lee reports.

Leia mais: Samsung Workers to Go Ahead With Strike
Bloomberg

China's Biotech Boom, AI Limits and Regulatory Edge

China's healthcare and biotechnology sector is expanding rapidly, driven by scale, speed and a more efficient drug approval regime. This segment examines how artificial intelligence is helping cut early drug design costs, while leaving much of the expensive clinical and manufacturing process unchanged. The discussion also looks at why China has become a global leader in clinical trials and biotech infrastructure, and how more realistic valuations are reshaping public markets in Hong Kong. Simone Song, Founding Partner of Ori Capital, joined David Ingles from the sidelines of Sohn Hong Kong Investment Leaders Conference on Insight with Haslinda Amin to share her outlook on the sector and its risks.

Leia mais: China's Biotech Boom, AI Limits and Regulatory Edge